Tissue manufacturing unlocked.
Commercially viable scale with automated manufacturing.
Latest News
Therapies work in the clinic, but are failing to scale.
The bottleneck is manual production.
Mytos’ automation enables scaling in months not years,
at lower costs than manual.
4×
Faster
Scaling
10×
Batches
Per Cleanroom
40%
Lower Cost
Per batch
10×
Fewer
FTE hours
Leading teams scale with Mytos.
“The Mytos iDEM system, together with our bioinformatics and other enabling technologies, allows us to scale out for Phase 3 and ultimately commercialization, making more product at lower cost.”
Kim Raineri CTO · Aspen Neuroscience You bring the science, We bring scale.
